Search
Bioventus Inc
BVSAdd to Watchlist
8.710USD
+0.170+1.99%
Close 06/18, 16:00（ET）Quotes delayed by 15 min
590.09MMarket Cap
20.38P/E TTM
Earnings Forecast
Currency: USD Updated: 2026-06-18The current earnings forecast score of Bioventus Inc is 8.40, ranking 37 out of 203 in the Healthcare Equipment & Supplies industry. The average price target is 15.00, with a high of 15.00 and a low of 15.00.
Analyst Rating
Based on
5
analysts
Buy
Current Rating
14.800
Target Price
+69.92%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
117
Total
6
Median
9
Average
Company name
Ratings
Analysts
Bioventus Inc
BVS
5
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Stryker Corp
SYK
32
Zimmer Biomet Holdings Inc
ZBH
31
Abbott Laboratories
ABT
30
1
2
3
...
24
Support & Resistance
Relevant data have not been disclosed by the company yet.
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
FAQs
What is Bioventus Inc's expected revenue for the next quarter?
Bioventus Inc's expected revenue is 155.45M.
What is Bioventus Inc's price target?
Analysts forecast that Bioventus Inc's price target is USD 15.00, with the highest forecast at USD 15.00 and the lowest forecast at USD 15.00.
How have Bioventus IncBVS's recent earnings per share performed?
The market expectation was USD 0.05, while Bioventus IncBVS's earnings per share (EPS) for the previous quarter was USD 0.22. EPS for the next quarter is expected at USD 0.22.
What is the analyst rating for Bioventus Inc?
Based on the ratings of Bioventus Inc's stock from 5 analysts, most analysts support a Buy trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as Buy. Please note that this is not trading advice. You still need to conduct your own analysis.
